원료의약품
Sitagliptin Phosphate (시타글립틴인산염)
KDMF APIs
Sitagliptin Phosphate
품목명 (한글) | 시타글립틴인산염 |
|---|---|
분류 | 기타의 대사성 의약품 |
CAS No. | 654671-78-0 |
KDMF 등록번호 | 수5217-4-ND |
제조원 | Mylan Laboratories Limited(Unit-1) |
규격 | In-house |
품목 정보
IUPAC Name | (3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one |
|---|---|
Synonyms | Sitagliptin |
Description | Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar. Sitagliptin was granted FDA approval on October 16, 2006. |
Certificate of Analysis | If you need more information, please contact us. |
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신드립니다. (02-579-1056 · ace@acebiopharm.com)